(Q43578067)

24 November 2017

The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults (English)

1 reference

24 November 2017

1 reference

1 reference

Christopher S Ambrose

series ordinal

1

1 reference

24 November 2017

Xionghua Wu

2

1 reference

PubMed ID

23261050

24 November 2017

language of work or name

English

0 references

publication date

20 December 2012

1 reference

24 November 2017

1 reference

24 November 2017

31

1 reference

24 November 2017

6

1 reference

24 November 2017

857-860

1 reference

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.028

Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.028

Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.028

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.028

Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.028

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.028

A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.12.028

10.1016/J.VACCINE.2012.12.028

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

23261050